Enhabit, Inc. (NYSE: EHAB)

Enhabit, Inc., known by its stock symbol EHAB, operates in the healthcare industry, specializing in home health and hospice services across the United States. The company's main business activities involve providing a spectrum of services to patients in their homes, including skilled nursing, various therapies, medical social work, and home health aide services.

Enhabit's revenue is primarily generated through its two segments: home health and hospice. The home health segment offers a range of Medicare-certified skilled home health services, catering to patients who require skilled care in their homes. This segment is the nation's fourth-largest provider of Medicare-certified skilled home health services, based on 2022 Medicare revenues. As of December 31, 2023, Enhabit managed 255 home health agencies in 34 states, with over 207,000 patient admissions for the year ended December 31, 2023.

The hospice segment, on the other hand, provides high-quality hospice services to terminally ill patients and their families. As of December 31, 2023, this segment operated 110 locations across 34 states, with 105 of these locations co-located with Enhabit's home health agencies. This co-location strategy allows for continuity of care and minimizes gaps in service.

Enhabit's competitive advantages are attributed to its scale and density in targeted markets, disciplined operating model, clinical expertise, and award-winning culture. The company's operating model emphasizes the use of technology, with clinicians trained to utilize informatics for timely decision-making in the field. Enhabit's focus on high-quality care and related outcomes has resulted in superior clinical outcomes, including lower hospital readmission rates and improved patient satisfaction.

The company's growth strategy includes organic growth through existing operations, opening new locations, increasing Payor Innovation contracts, and shifting business to Medicare Advantage contracts that pay improved rates. Enhabit is also exploring strategic alternatives, such as a potential sale, merger, or other strategic transaction.

Enhabit's customer base includes a diverse range of patients, from older adults with chronic conditions and significant functional limitations to terminally ill patients and their families. The company's hospice segment serves the latter group, providing high-quality care and support during a difficult time.

In terms of its position within the industry, Enhabit is a strong player, known for its high-quality care and related outcomes. The company's scale and density in targeted markets, combined with its disciplined operating model and clinical expertise, position it well for continued growth and success.

The brand names and/or trade names of its products and services include Enhabit's home health and hospice services. These services are designed to provide high-quality care and support to patients in their own homes and during end-of-life care, respectively. Enhabit's commitment to quality care and its strategic growth initiatives make it a significant player in the healthcare industry.